Page 44 - 66_01

J. CORTIJO ANAL. REAL ACAD. FARM.

(25) HALL I.P. Isoenzymes selective phosphodiesterase inhibitors: potential
clinical uses. Br J Clin Pharmac, (1993); 35: 1-7.

(26) PODZUWEIT T, MÜLLER A, NENNSTIEL P. Selective inhibition of
the GMP-stimulated cyclic nucleotide phosphodiesterase from pig and
human myocardium (abstract). J Mol Cell, (1992); 24 (suppl V): 102.

(27) KEREIAKES D, CHATTERJEE K, PARMLEY W.W, et al..
Intravenous and oral MDL 17043 (a new inotrope-vasodilatador agent)
in congestive heart failure: haemodynamic and clinical evaluation in 38
patients. J Am Coll Cardiol, (1984); 4: 884-889.

(28) JASKI B.E, FIFER M.A, WRIGHT R.F, et al.. Positive inotropic and
vasodilatador actions of milrinone in patients with severe congestive
heart failure. Dose-response relationships and comparison to
nitroprusside. J Clin Invest, (1985); 75: 643-649.

(29) MURRAY K.J, ENGLAND P.J, HALLAM T.J, et al.. The effects of
siguazodan, a selective phosphodiesterase inhibitor on human platelet
function. Br J Pharmacol, (1990); 99: 612-616.

(30) LEEMAN M, LEJEUNE P, MEOT C, et al.. Reduction in pulmonary
hypertension and in airway resistance by enoximone (MDL 17043) in
descompensated COPD. Chest, (1987); 91: 626-666.

(31) CORTIJO J, BOU J, BELETA J, et al.. Investigation into the role of
phosphodiesterase 4 in bronchorelaxation, including studies with human
bronchus. Br J Pharmacol, (1993); 108: 562-568.

(32) DENT G, RABE K, GIEMBYCZ M.A, et al.. Inhibition of eosinophil
respiratory burst activity by type 4 but not type 3 selective cyclic AMP
phosphodiesterase inhibitors. Am Rev Respir Dis, (1990); 141: A478.

(33) NIELSON C.P, VESTAL R.E, STURM R.J, et al.. Effect of selective
phosphodiesterase inhibitors on the polymorphonuclear leukocyte
respiratory burst. J Allergy Clin Immunol, (1990); 86: 801-808.

(34) ORTIZ J.L, CORTIJO J, VALLÉS J.M, et al.. Rolipram inhibits PAF-
induced airway microvascular leakage in guinea-pigs: a comparison with
milrinone and teophylline. Fundam Clin Pharmacol, (1992); 6: 247-
249.

(35) ORTIZ J.L, CORTIJO J, VALLÉS J.M, et al.. Rolipram inhibits airway
microvascular leakage induced by platelet-activating factor, histamine
and bradykinin in guinea-pigs. J Pharm Pharmacol, (1993); 45: 1090-
1092.

(36) CORTIJO J, ORTIZ J.L, VALLÉS J.M, et al.. Inhaled rolipram and
zaprinast inhibit airway microvascular leakage produced by inhaled
platelet-activating factor in the guinea-pig. Br J Pharmacol, (1994);
112: 592P.

22